[Secondary osteoporosis. Cancer treatment-induced bone loss.]

[Secondary osteoporosis. Cancer treatment-induced bone loss.] Clin Calcium. 2018;28(12):1665-1670 Authors: Imanishi Y Abstract Adjuvant aromatase inhibitor therapy for hormone receptor-positive breast cancer in postmenopausal women, and gonadotropin-releasing hormone agonist for prostate cancer in men, are associated with bone loss, leading to the increment of fracture risks. Assessment of bone status, improvement of life style such as diet and exercise, and osteoporosis treatments are essential to keep good bone health in cancer treatment-induced bone loss. PMID: 30487333 [PubMed - in process]
Source: Clinical Genitourinary Cancer - Category: Cancer & Oncology Authors: Tags: Clin Calcium Source Type: research